Page last updated: 2024-11-04

sulfadiazine and Porphyrias

sulfadiazine has been researched along with Porphyrias in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
EL-MOFTY, AM1

Other Studies

1 other study available for sulfadiazine and Porphyrias

ArticleYear
CUTANEOUS PORPHYRIA IN EGYPTIANS.
    The British journal of dermatology, 1964, Volume: 76

    Topics: Adolescent; Alcoholism; Child; Classification; Dermatitis, Phototoxic; Egypt; Genetics, Medical; Ger

1964